Painreform is trading at $0.71, down 7.69% in pre-market on November 5; the reason for the decline remains unclear.
- No verified company-specific announcement has been identified for November 5 explaining the decline.
- November 3 Dotz Nano term-sheet news concerned a proposed platform transaction, but available reporting does not link it to this drop.
- XBI was up pre-market, opposite Painreform’s move. November 4 volume was 453,704 shares; pre-market volume was unavailable.